|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.06 EUR | -0.18% |
|
-.--% | -3.15% |
| 15/07 | INDEX-MONITOR: Medios replaces Synlab in the SDax | DP |
| 15/07 | SYNLAB AG(XTRA:SYAB) dropped from Germany SDAX (Total Return) Index | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
| Capitalization | 2.43B 2.69B 226B | P/E ratio 2024 * |
29.9x | P/E ratio 2025 * | 36.9x |
|---|---|---|---|---|---|
| Enterprise value | 3.74B 4.15B 348B | EV / Sales 2024 * |
1.38x | EV / Sales 2025 * | 1.42x |
| Free-Float |
14.25% | Yield 2024 * |
0.72% | Yield 2025 * | 0.72% |
More valuation ratios
* Estimated data
More news
Last Transcript: SYNLAB AG
| 1 day | -0.18% | ||
| 3 months | -0.36% | ||
| 6 months | -4.16% | ||
| Current year | -3.15% |
Current year
10.10
12.43
1 year
8.0212.43
3 years
6.6825.00
5 years
6.6825.00
10 years
6.6825.00
| Director | Title | Age | Since |
|---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 57 | 26/21/26 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 26/21/26 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 11/21/11 |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/21/11 |
| Founder | 63 | 01/98/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 125 M€ | -.--% | ||
| 0.55% | 17 M€ | -.--% | - | |
| 0.18% | 18 M€ | +7.68% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.18% | -.--% | +21.54% | -48.56% | 2.7B | ||
| +0.18% | -1.77% | -12.63% | -35.75% | 8.73B | ||
| -1.23% | -5.85% | +102.96% | +104.15% | 4.62B | ||
| -0.77% | -1.14% | +50.79% | -17.22% | 3.35B | ||
| -1.05% | -2.91% | +14.49% | -68.97% | 2.06B | ||
| -1.67% | +0.84% | -52.37% | -74.34% | 1.82B | ||
| +4.89% | +4.89% | +16.99% | -27.26% | 1.63B | ||
| -0.26% | -0.02% | +49.65% | -25.65% | 1.31B | ||
| -2.93% | +0.75% | +90.04% | - | 1.12B | ||
| -2.50% | -7.14% | -8.77% | -56.42% | 1.08B | ||
| Average | -0.55% | -0.41% | +27.27% | -27.78% | 2.84B | |
| Weighted average by Cap. | -0.38% | -1.25% | +25.07% | -15.98% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.71B 3B 252B | 2.85B 3.15B 265B |
| Net income | 81M 89.77M 7.54B | 67M 74.26M 6.23B |
| Net Debt | 1.31B 1.45B 122B | 1.62B 1.8B 151B |
More financial data
* Estimated data
Employees
27,000
Calendar
07/11/2024
- Q3 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.06EUR
Average target price
10.00EUR
Spread / Average Target
-9.58%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SYAB Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition